Pra health sciences, inc. (PRAH)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13
Service revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

399,841

394,249

372,320

362,265

345,096

336,518

331,968

323,759

320,063

311,422

311,352

324,362

Reimbursement revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

53,414

61,598

57,903

66,682

58,414

56,330

56,610

46,205

57,274

46,123

43,388

54,854

Revenue

783,708

800,240

780,691

763,309

722,022

729,648

717,596

722,841

701,837

655,896

582,009

533,724

487,760

472,386

453,255

455,847

430,223

428,947

403,510

392,848

388,578

369,964

377,337

357,545

354,740

379,216

Operating expenses:
Selling, general and administrative expenses

106,957

103,484

95,542

98,804

97,095

96,371

92,553

91,169

91,702

92,217

79,307

76,195

74,268

70,245

67,190

68,468

63,990

63,586

63,091

58,905

60,835

73,689

63,432

56,010

60,839

69,730

Transaction-related costs

609

1,263

572

0

0

3,108

43,837

450

-11,578

75,893

11,741

35

40

13,049

0

2,869

28,916

-

-

-

-

-

-

-

-

29,180

Depreciation and amortization expense

32,278

29,435

29,264

28,591

27,608

28,084

28,270

28,554

27,339

28,081

18,853

16,101

15,192

17,260

17,708

17,585

16,953

19,735

19,762

19,220

19,235

23,425

23,903

24,598

24,638

25,333

(Gain) loss on disposal of fixed assets, net

19

-159

-256

-555

-88

-99

15

-50

14

-118

-8

-150

-82

-463

-219

-43

-28

-

-256

-195

-

-

-8

-

-

-

Income from operations

63,180

101,401

95,788

88,013

78,723

96,756

38,812

73,796

71,948

3,613

57,776

64,850

49,986

38,241

54,814

50,348

18,946

43,861

49,179

38,321

32,937

11,705

16,974

17,436

10,724

-22,657

Interest expense, net

-13,487

-14,153

-12,974

-12,491

-12,369

-13,539

-14,423

-14,612

-14,825

-15,641

-11,557

-10,004

-9,527

-12,388

-13,779

-13,380

-15,366

-15,683

-15,255

-15,416

-15,393

-18,329

-21,026

-20,818

-21,766

-23,703

Loss on modification or extinguishment of debt

-

-

-1,855

-

-

-

-454

-

-

-

-3,089

-

-

-16,693

0

0

-21,485

-

-

-

-

-23,652

0

0

-1,384

-7,211

Foreign currency gains, net

7,842

-4,122

5,408

-9,671

6,128

373

-1,809

476

-83

-4,618

-12,794

-14,956

-7,254

14,765

1,182

10,872

-2,790

5,251

3,697

-3,966

9,066

8,979

10,658

-5,387

-3,712

-4,117

Other expense, net

-4

239

15

8

-88

-170

-68

66

-199

-104

5

-65

-140

-

20

-105

-

73

-947

-96

-464

-2,021

-58

-116

-59

1,180

Income before income taxes

57,531

-

-

-

72,394

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest

-

-

86,382

65,859

-

82,922

22,058

59,726

56,841

-28,684

30,341

39,825

33,065

24,617

42,237

47,735

-20,695

33,502

36,674

18,843

26,146

-23,318

6,548

-8,885

-16,197

-56,508

Provision for income taxes

16,871

6,491

3,375

24,804

28,138

11,840

20,248

17,490

17,654

-12,458

-18,241

10,193

7,883

10,625

10,821

12,312

-5,264

5,663

10,696

5,623

8,022

-1,534

4,899

-5,186

-6,333

-17,186

Income before equity in income of unconsolidated joint ventures

-

-

83,007

41,055

-

71,082

1,810

42,236

39,187

-16,226

48,582

29,632

25,182

13,992

31,416

35,423

-15,431

27,839

25,978

13,220

18,124

-21,784

1,649

-3,699

-9,864

-39,322

Income (Loss) from Equity Method Investments

-

-

0

0

-

25

44

46

28

31

24

26

42

33

33

3,247

-538

-1,209

-2,319

-805

937

-1,036

-474

-357

-177

-621

Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

40,660

74,801

83,007

41,055

44,256

71,107

1,854

42,282

39,215

-16,195

48,606

29,658

25,224

14,025

31,449

38,670

-15,969

28,504

23,659

12,415

17,187

-22,820

1,175

-4,056

-10,041

-39,943

Net income attributable to noncontrolling interest

0

0

0

-73

172

-345

359

305

234

-147

401

112

0

-

0

-

-

-

-

-

-

-

-

-

-

-

Net income attributable to PRA Health Sciences, Inc.

40,660

74,801

83,007

41,128

44,084

71,452

1,495

41,977

38,981

-16,048

48,205

29,546

25,224

-

31,449

38,670

-

-

-

-

-

-

-

-

-

-

Earnings Per Share [Abstract]
Basic (in dollars per share)

0.65

1.18

1.28

0.63

0.68

1.11

0.02

0.66

0.61

-0.26

0.77

0.47

0.41

0.23

0.52

0.64

-0.27

0.47

0.39

0.21

0.29

-0.51

0.03

-0.10

-0.25

-1.02

Diluted (in dollars per share)

0.63

1.15

1.25

0.62

0.66

1.07

0.02

0.64

0.59

-0.25

0.73

0.45

0.39

0.24

0.49

0.60

-0.27

0.45

0.37

0.20

0.27

-0.51

0.03

-0.10

-0.25

-1.02

Weighted average common shares outstanding:
Weighted Average Number of Shares Outstanding, Basic

62,933

62,733

64,771

65,328

65,192

64,827

64,261

63,874

63,530

63,208

62,730

62,232

61,578

61,303

60,937

60,597

60,199

60,124

60,050

59,871

59,815

50,768

40,284

40,268

40,268

39,337

Weighted Average Number of Shares Outstanding, Diluted

64,339

64,193

66,213

66,763

66,847

66,619

66,506

66,078

66,161

66,054

65,872

65,727

65,439

68,678

64,521

64,410

60,199

63,596

63,504

62,951

62,777

48,980

42,072

40,268

40,268

39,337

Direct Costs [Member]
Cost of revenues

403,862

386,100

389,304

386,249

377,888

365,717

371,422

381,655

381,432

368,880

326,865

300,611

287,512

274,355

259,910

254,936

243,487

234,882

212,808

219,877

218,961

214,943

215,746

213,378

215,151

222,776

Reimbursable expenses
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization

176,841

178,398

169,965

161,097

140,620

139,513

142,717

147,167

141,008

87,094

87,459

75,782

60,680

58,773

53,414

61,598

57,903

66,682

58,414

56,330

56,610

46,205

57,274

46,123

43,388

54,854

Reimbursable investigator fees
Cost of revenues

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-